http://online.wsj.com/article/SB125503764592374389.html?mod=rss_Health
LONDON -- GlaxoSmithKline PLC has spent five years fashioning itself into a one-stop pandemic shop. Now, as the swine-flu virus sweeps the globe, the U.K.-based drug giant will find out whether the world is buying.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment